The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations: A report from the BEGAMI study

Conclusion:
Sitagliptin did not improve endothelial function in patients with ACS and newly detected glucose perturbations.

Source: Diabetes and Vascular Disease Research - June 16, 2014 Category: Endocrinology Authors: Hage, C., Brismar, K., Lundman, P., Norhammar, A., Ryden, L., Mellbin, L. Tags: Brief Reports Source Type: research